Welcome to our dedicated page for Esquire Finl Hldgs SEC filings (Ticker: ESQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Esquire Financial Holdings, Inc. (NASDAQ: ESQ) SEC filings page provides access to the company’s official regulatory disclosures as a Maryland-incorporated financial holding company. Esquire’s common stock is registered under Section 12(b) of the Securities Exchange Act of 1934 and trades on The Nasdaq Stock Market LLC under the symbol ESQ. Through these filings, investors can review how Esquire reports its financial condition, operating results, capital position, and material corporate events.
Esquire uses current reports on Form 8-K to announce key developments such as quarterly earnings results, regular quarterly dividends for common stockholders, and significant corporate actions like its new headquarters lease in Jericho, New York. These 8-K filings often reference attached press releases and investor presentations that provide additional detail on net income, returns on average assets and equity, net interest margin, loan and deposit growth, credit quality, and noninterest income from its payment processing platform.
In addition to 8-Ks, investors can consult Esquire’s annual reports on Form 10-K and quarterly reports on Form 10-Q (when available in the broader SEC record) for comprehensive discussions of its business model as a full-service commercial bank focused on the litigation industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. These periodic reports typically include information on segment performance, securities and loan portfolios, funding through core deposits, and risk management practices.
Stock Titan’s filings page is designed to surface ESQ filings as they are posted to the SEC’s EDGAR system and to pair them with AI-powered summaries. These summaries can help explain complex sections of lengthy documents, highlight key changes from prior periods, and point out items such as dividend declarations, capital ratios, and developments in Esquire’s national litigation platform and payment processing operations. Users can also track insider and executive share transactions through Form 4 filings when they are available, gaining additional context on equity ownership and incentives.
Esquire Financial Holdings, Inc.
These holdings include multiple grants of restricted stock that vest in three equal annual installments beginning on various dates from December 19, 2023 through January 30, 2028. The filer also holds stock options covering 29,250 shares of common stock with a $12.5 exercise price, which became exercisable on 09/01/2017 and expire on 09/01/2026 and are described as fully vested.
Esquire Financial Holdings, Inc. executive vice president and chief operating officer Eric S. Bader reported equity transactions in company stock. On 12/16/2025, 3,293 shares of common stock were disposed of in a transaction coded "F" at $106.82 per share, typically indicating shares withheld to cover taxes on vesting. After this, he beneficially owned 126,365 shares of common stock directly and 2,000 shares indirectly through an IRA. He also held fully vested stock options with an exercise price of $12.5 per share covering 14,125 shares of common stock, exercisable from
Esquire Financial Holdings, Inc.common stock2,229 shares$106.82100,418 shares1,947 shares
The filing also lists fully vested stock options$12.57,500 shares11,125 shares
Esquire Financial Holdings, Inc. reported an insider stock transaction by its SVP & Chief Financial Officer. On 12/16/2025, the officer disposed of 240 shares of common stock in a transaction coded “F” at a price of $106.82 per share, typically indicating shares withheld to cover taxes on equity vesting. Following this, the officer beneficially owns 16,622 shares of common stock directly and 3,250 shares indirectly through an IRA.
The filing also lists several stock option awards on common stock with exercise prices from $20.85 to $48.32 and expiration dates between 12/10/2028 and 12/15/2033. Some options are fully vested, while others vest in three equal annual installments beginning on dates in 2023 and 2024.
Esquire Financial Holdings, Inc. reported that one of its directors received a grant of 753 shares of restricted common stock on December 10, 2025, at a stated price of $0 per share. These restricted shares are scheduled to vest 100% on December 10, 2026.
After this grant, the reporting person beneficially owns 59,400 shares of common stock, including multiple prior restricted stock awards that vest in annual installments from December 19, 2023 through December 15, 2027. The director also holds 1,500 fully vested stock options with an exercise price of $24.9 per share, expiring on December 10, 2028.
Esquire Financial Holdings, Inc. disclosed that one of its directors acquired 753 shares of restricted common stock on December 10, 2025 at a price of $0 per share. These restricted shares vest 100% on December 10, 2026.
Following this award, the director beneficially owns 15,716 shares of common stock directly, along with indirect holdings of 25,500 shares as trustee for a trust, 12,600 shares through a limited partnership, 79,033 shares through another trust, and 21,001 shares through a profit sharing plan. The filing notes that these totals include multiple restricted stock grants scheduled to vest in three equal annual installments beginning on various dates between December 19, 2023 and December 15, 2027.
Esquire Financial Holdings, Inc. reported that one of its directors acquired 753 shares of common stock on December 10, 2025 at a price of $0, reflecting a grant of restricted stock.
These 753 restricted shares vest 100% on December 10, 2026. Following this award, the director beneficially owns 4,436 common shares directly and also holds 9,786 shares indirectly through an LLC II, 6,000 shares indirectly through the director's mother, and 127,531 shares indirectly through an LLC I, including restricted stock scheduled to vest in three equal annual installments beginning in 2026 and 2027.
Esquire Financial Holdings, Inc. reported an insider equity award by one of its directors. On 12/10/2025, the director acquired 1,836 shares of common stock as restricted stock at a price of $0. These restricted shares vest 100% on December 10, 2026.
Following this grant, the director beneficially owns 49,267 shares of common stock directly, 12,910 shares indirectly through a trust, and 36,000 shares indirectly through an IRA. The director also holds fully vested stock options covering 20,000 shares of common stock with an exercise price of $12.5 per share, expiring on 09/01/2026.
Esquire Financial Holdings, Inc. director reported acquiring 753 shares of restricted common stock on December 10, 2025 at a stated price of $0 per share. Following this grant, the director beneficially owns 72,401 shares of common stock directly.
The newly reported 753 restricted shares vest 100% on December 10, 2026. The total holding includes multiple prior restricted stock awards that vest in three equal annual installments beginning on December 19, 2023, December 9, 2025, December 19, 2026, December 3, 2027, and December 15, 2027. The director also holds fully vested stock options for 2,000 shares at $20.85 expiring December 16, 2030 and 1,750 shares at $31.04 expiring December 9, 2031.
Esquire Financial Holdings, Inc. disclosed that one of its directors received a grant of 753 shares of restricted common stock on December 10, 2025. The shares were awarded at $0 per share and are scheduled to vest 100% on December 10, 2026.
After this grant, the director beneficially owns 142,679 shares of common stock directly, which include multiple restricted stock awards that vest in three equal annual installments beginning on dates between December 19, 2023 and December 15, 2027. In addition, the director indirectly owns 2,500 shares through an insurance trust I and 2,500 shares through an insurance trust II.
FAQ
What is the current stock price of Esquire Finl Hldgs (ESQ)?
What is the market cap of Esquire Finl Hldgs (ESQ)?
